Human monocytes possess a serine protease activity capable of degrading HIV-1 reverse transcriptase in vitro

被引:9
作者
Château, MT
Robert-Hebmann, W
Devaux, C
Lazaro, JB
Canard, B
Coux, O
机构
[1] CNRS, Ctr Rech Biochim Macromol, F-34293 Montpellier 05, France
[2] CNRS, Inst Biol, Lab Infect Retrovirales & Signalisat Cellulaire, F-34060 Montpellier, France
[3] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA
[4] CNRS, Ecole Super Ingenieurs Luminy Architecture & Fonc, F-13288 Marseille 9, France
[5] Univ Montpellier 1, Fac Pharm, F-34060 Montpellier 01, France
关键词
HIV-1; reverse transcriptase; human monocytes; U937; differentiation; serine protease; proteolysis;
D O I
10.1006/bbrc.2001.5252
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) plays a central role in the virus replication cycle. We found that HIV-1 RT was rapidly degraded when incubated with cell extracts obtained from human peripheral blood cells. The proteolytic activity responsible for the in vitro degradation of RT was present in monocytes and their precursors. Interestingly, this activity was downregulated upon cell activation or differentiation along the macrophage pathway. The proteolytic process appears specific for HIV-1 RT since other HIV-1 proteins were not degraded upon incubation in the same extracts. Although the degradation of RT was unaffected by specific proteasome inhibitors, it could be inhibited by PMSF and aprotinin, suggesting the involvement of a serine protease. Upon cell fractionation, this serine protease was found to be associated with the microsomal fraction and displayed an apparent molecular weight of approximately 2000 kDa, as determined by gel filtration. Our results suggest that a giant serine protease, different from tripeptidyl peptidase II, is involved in the in vitro degradation of HIV-1 RT. The possibility of an in vivo interaction between HIV-1 RT and a cell-type-specific serine protease is discussed. (C) 2001 Academic Press.
引用
收藏
页码:863 / 872
页数:10
相关论文
共 32 条
[1]   ASSOCIATION OF INTEGRASE, MATRIX, AND REVERSE-TRANSCRIPTASE ANTIGENS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH VIRAL NUCLEIC-ACIDS FOLLOWING ACUTE INFECTION [J].
BUKRINSKY, MI ;
SHAROVA, N ;
MCDONALD, TL ;
PUSHKARSKAYA, T ;
TARPLEY, WG ;
STEVENSON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :6125-6129
[2]   The motif D loop of human immunodeficiency virus type 1 reverse transcriptase is critical for nucleoside 5′-triphosphate selectivity [J].
Canard, B ;
Chowdhury, K ;
Sarfati, R ;
Doublié, S ;
Richardson, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35768-35776
[3]   DETERMINATION OF VIRAL-PROTEINS PRESENT IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PREINTEGRATION COMPLEX [J].
FARNET, CM ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1991, 65 (04) :1910-1915
[4]   A FAMILY OF SERINE PROTEASES EXPRESSED EXCLUSIVELY IN MYELO-MONOCYTIC CELLS SPECIFICALLY PROCESSES THE NUCLEAR FACTOR-KAPPA-B SUBUNIT P65 IN-VITRO AND MAY IMPAIR HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION IN THESE CELLS [J].
FRANZOSO, G ;
BISWAS, P ;
POLI, G ;
CARLSON, LM ;
BROWN, KD ;
TOMITAYAMAGUCHI, M ;
FAUCI, AS ;
SIEBENLIST, UK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1445-1456
[5]   HIV NUCLEAR IMPORT IS GOVERNED BY THE PHOSPHOTYROSINE-MEDIATED BINDING OF MATRIX TO THE CORE DOMAIN OF INTEGRASE [J].
GALLAY, P ;
SWINGLER, S ;
SONG, JP ;
BUSHMAN, F ;
TRONO, D .
CELL, 1995, 83 (04) :569-576
[6]   Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex [J].
Haffar, OK ;
Popov, S ;
Dubrovsky, L ;
Agostini, I ;
Tang, H ;
Pushkarsky, T ;
Nadler, SG ;
Bukrinsky, M .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 299 (02) :359-368
[7]   HUMAN-LEUKEMIC MODELS OF MYELOMONOCYTIC DEVELOPMENT - A REVIEW OF THE HL-60 AND U937 CELL-LINES [J].
HARRIS, P ;
RALPH, P .
JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 37 (04) :407-422
[8]  
HASS R, 1989, EUR J CELL BIOL, V48, P282
[9]  
Herszènyi L, 1999, CANCER, V86, P1135, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1135::AID-CNCR6>3.0.CO
[10]  
2-2